OS12.6.A Combination therapy of CAR-NK-cells and anti-PD-1 results in high efficacy against advanced-stage glioblastoma in a syngeneic mouse model and induces protective anti-tumor immunity in vivo.

Saved in:
Bibliographic Details
Title: OS12.6.A Combination therapy of CAR-NK-cells and anti-PD-1 results in high efficacy against advanced-stage glioblastoma in a syngeneic mouse model and induces protective anti-tumor immunity in vivo.
Authors: Strassheimer, F, Strecker, M I, Alekseeva, T, Macas, J, Demes, M C, Mildenberger, I C, Tonn, T, Wild, P J, Sevenich, L, Reiss, Y, Harter, P N, Plate, K H, Wels, W S, Steinbach, J P, Burger, M C
Source: Neuro-oncology 2021 Supplement; Vol. 23.
Journal Info: Publisher: Oxford University Press / USA ISSN: 1522-8517
Database: MEDLINE Ultimate
Description
ISSN:1523-5866
DOI:10.1093/neuonc/noab180.049